Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/1276 stock hub

HKG/1276 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1276is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

403.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1276

In the news

Latest news · HKG/1276

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.3

P25 11.7P50 18.9P75 41.4

Trailing P/E43.7

P25 10.7P50 17.9P75 38.5

ROE14.5

P25 -14.7P50 2P75 9.4

ROIC34.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1276 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

CNY

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	20,602
Employees Change	364%
Employees Change Percent	1.8
Enterprise value	HKD 357.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	HKD 403.4B
Price	HKD 64.55
Price currency	HKD
Rev Per Employee	1,796,663.41x
Sector	Healthcare
Sic	2834
Symbol	hkg/1276
Website	https://www.hengrui.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.29%
EV Earnings	38.72x
EV/EBIT	35.96x
EV/EBITDA	32.69x
EV/FCF	36.97x
EV/Sales	9.53x
FCF yield	2.4%
Forward P/E	35.29x
P/B ratio	5.53x
P/E ratio	43.71x
P/S ratio	10.9x
PE Ratio10 Y	61.6x
PE Ratio3 Y	56.68x
PE Ratio5 Y	59.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.5%
EBITDA Margin	29.03%
FCF margin	26.11%
Gross margin	86.27%
Gross Profit	HKD 31.9B
Gross Profit Growth	11.54%
Gross Profit Growth Q	14.87%
Gross Profit Growth3 Y	16.47%
Gross Profit Growth5 Y	1.87%
Net Income	HKD 9.2B
Net Income Growth	18.67%
Net Income Growth Q	21.78%
Net Income Growth3 Y	27.6%
Net Income Growth5 Y	4.52%
Pretax Margin	28.22%
Profit Margin	24.93%
Profit Per Employee	HKD 447,962
ROA	8.8
Roa5y	6.83
ROCE	13.14
ROE	14.54
Roe5y	12.69
ROIC	34.38
Roic5y	23.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
FCF Growth	84.3%
FCF Growth5 Y	45.81%
OCF Growth	70.55%
OCF Growth Q	41.66%
OCF Growth10 Y	16.72%
OCF Growth3 Y	104.99%
OCF Growth5 Y	40.59%
Revenue Growth	11.55x
Revenue Growth Q	12.98x
Revenue Growth3 Y	15.22x
Revenue Growth5 Y	2.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.53
Assets	HKD 81B
Cash	HKD 46.2B
Current Assets	HKD 59.9B
Current Liabilities	HKD 6.5B
Debt	HKD 76.7M
Debt EBITDA	HKD 0.01
Debt Equity	HKD 0
Debt FCF	HKD 0.01
Equity	HKD 72.9B
Interest Coverage	2,228.3
Liabilities	HKD 8.1B
Long Term Assets	HKD 21.1B
Long Term Liabilities	HKD 1.6B
Net Cash	HKD 46.1B
Net Cash By Market Cap	HKD 11.43
Net Cash Growth	68.42%
Net Debt EBITDA	HKD -4.29
Net Debt Equity	HKD -0.63
Net Debt FCF	HKD -4.77
Tangible Book Value	HKD 69.8B
Tangible Book Value Per Share	HKD 10.39
WACC	5.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.23
Inventory Turnover	1.69
Net Working Capital	HKD 6.6B
Quick ratio	8.36
Working Capital	HKD 52.7B
Working Capital Turnover	HKD 0.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	HKD 0.23
Dividend Years	1
Dividend Yield	0.35%
Ex Div Date	2026-04-29
Last Dividend	HKD 0.23
Payout Ratio	15.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	73.72
50-day SMA	65.65
50-day SMA vs 200-day SMA	50under200
All Time High	95.2
All Time High Change	-32.2%
All Time High Date	2025-10-02
All Time Low	52.5
All Time Low Change	22.95%
All Time Low Date	2025-05-26
ATR	2.58
Beta	0.17
Ch YTD	-9.4
High	65.8
High52	95.2
High52 Date	2025-10-02
High52ch	-32.2%
Low	64.05
Low52	52.5
Low52 Date	2025-05-26
Low52ch	22.95%
Ma50ch	-1.68%
Price vs 200-day SMA	-12.44%
RSI	44.25
RSI Monthly	0
RSI Weekly	43.7
Sharpe ratio	0.5x
Sortino ratio	1.05
Total Return	0.35%
Tr YTD	-9.09
Tr1m	-2.81%
Tr1w	-4.23%
Tr3m	-4.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 9.8B
Operating Income Growth	22.87
Operating Income Growth Q	26.86
Operating Income Growth3 Y	41.71
Operating Income Growth5 Y	5.99
Operating margin	26.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,722,932,709%
Net Borrowing	-56,074,972.4
Shares Insiders	0.12%
Shares Institutions	28.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 9.7B
Average Volume	2,454,418.8x
Bv Per Share	10.77
CAPEX	HKD -3.4B
Ch1m	-3.15
Ch1w	-4.23
Ch3m	-4.58
Ch6m	-7.72
Change	-1.53%
Change From Open	-1.53
Close	65.55
Days Gap	0
Depreciation Amortization	947,080,729.3
Dollar Volume	128,367,034.8
Earnings Date	2026-08-20
EBIT	HKD 9.8B
EBITDA	HKD 10.7B
EPS	HKD 1.39
F Score	4
FCF	HKD 9.7B
FCF EV Yield	2.7x
Financing CF	9,385,519,465
Fiscal Year End	December
Founded	1,970
Graham Number	19.6885
Graham Upside	-69.5
Income Tax	HKD 1.2B
Investing CF	-3,333,357,761
Is Primary Listing	0
Last Earnings Date	2026-03-25
Last Report Date	2026-03-31
Lynch Fair Value	HKD 7.38
Lynch Upside	-88.56
Ma150	71.77
Ma150ch	-10.06%
Ma20	66.72
Ma20ch	-3.25%
Net CF	18,245,411,252
Next Earnings Date	2026-08-20
Open	65.55
P FCF Ratio	41.74
P OCF Ratio	30.95
Payment Date	2026-05-27
Position In Range	28.57
Ppne	9,360,213,446.2
Price Date	2026-05-08
Price EBITDA	HKD 37.55
Ptbv Ratio	5.78
Relative Volume	0.81x
Revenue	37,014,859,528x
Tax By Revenue	3.28x
Tax Rate	11.62%
Tr6m	-7.4%
Volume	1,988,645
Z Score	35.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1276 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.23 annual per share

Payout ratio

+15.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-04-29

Ownership

Who owns HKG/1276?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/1276 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.3

Neutral momentum band

Price vs 200-day MA

-12.4%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1276

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1276 stock rating?

hkg/1276 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1276 analysis?

The full report lives at /stocks/hkg/1276/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1276?

The latest report frames hkg/1276 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1276 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.